UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2002

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

7-hydroxystaurosporine

DRUG

fluorouracil

DRUG

leucovorin calcium

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00042861 - UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors | Biotech Hunter | Biotech Hunter